{ "source": "Nasdaq Nordic Company News", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "status": "retrieved", "company": "BioInvent International", "reports": [ { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:23Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari - mars 2026", "category": "Interimsrapport", "date": "2026-04-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2026, "quarter": "q1", "period": "2026-q1", "report_key": "2026:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=be158a6dd3920b5c915eb1cf51aaf26d9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\release.txt", "attachments": [ { "label": "BioInvent 2026 Q1 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a765f877b02a605a235a412ef9ad999ae", "final_url": "https://attachment.news.eu.nasdaq.com/a765f877b02a605a235a412ef9ad999ae", "filename": "BioInvent_2026_Q1_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\BioInvent_2026_Q1_SE.pdf", "content_type": "application/pdf", "size": 1640232, "sha256": "760646253561e826b991c899b5cef3cb5011cd352be5ea975efff2c17d64c8de", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\BioInvent_2026_Q1_SE.pdf", "filename": "BioInvent_2026_Q1_SE.pdf", "extension": ".pdf", "size": 1640232, "sha256": "760646253561e826b991c899b5cef3cb5011cd352be5ea975efff2c17d64c8de", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\extracted\\BioInvent_2026_Q1_SE\\BioInvent_2026_Q1_SE.txt", "text_chars": 52183, "metadata": { "page_count": 22, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2026-q1\\extracted\\BioInvent_2026_Q1_SE\\BioInvent_2026_Q1_SE.extraction.json" } } ], "announcement_id": "1438050", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:34Z", "company": "BioInvent International AB", "title": "BioInvent International AB publicerar årsredovisningen för 2025", "category": "Bokslut och Verksamhetsberättelse", "date": "2026-03-31", "language": "sv", "report_type": "annual-report", "fiscal_year": 2025, "quarter": "annual", "period": "2025-annual", "report_key": "2025:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b63c54630b6b77a174e8fb86a1012f0ba&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\release.txt", "attachments": [ { "label": "BioInvent AR 2025 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a487fe042126ce0a635def2e18fe5d002", "final_url": "https://attachment.news.eu.nasdaq.com/a487fe042126ce0a635def2e18fe5d002", "filename": "BioInvent_AR_2025_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\BioInvent_AR_2025_SE.pdf", "content_type": "application/pdf", "size": 7398504, "sha256": "efdccbf6e381225957a5e1d1ec52affbf07ebb50fb74e59db702d78f170bc384", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\BioInvent_AR_2025_SE.pdf", "filename": "BioInvent_AR_2025_SE.pdf", "extension": ".pdf", "size": 7398504, "sha256": "efdccbf6e381225957a5e1d1ec52affbf07ebb50fb74e59db702d78f170bc384", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\extracted\\BioInvent_AR_2025_SE\\BioInvent_AR_2025_SE.txt", "text_chars": 256078, "metadata": { "page_count": 79, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-annual\\extracted\\BioInvent_AR_2025_SE\\BioInvent_AR_2025_SE.extraction.json" } } ], "announcement_id": "1430332", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:37Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2025", "category": "Bokslutskommuniké", "date": "2026-02-26", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2025, "quarter": "q4", "period": "2025-q4", "report_key": "2025:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b63f1fa8542a4e536857a93ea14af0df4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\release.txt", "attachments": [ { "label": "BioInvent Q4 2025 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a7d93f053ec21ea8d08e351a192d6fb13", "final_url": "https://attachment.news.eu.nasdaq.com/a7d93f053ec21ea8d08e351a192d6fb13", "filename": "BioInvent_Q4_2025_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\BioInvent_Q4_2025_SE_Final.pdf", "content_type": "application/pdf", "size": 2480381, "sha256": "2d2727acac874bdb56f04acbbf3713f8b0f0cd5c63ed787ec40a0efb43b0e2a1", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\BioInvent_Q4_2025_SE_Final.pdf", "filename": "BioInvent_Q4_2025_SE_Final.pdf", "extension": ".pdf", "size": 2480381, "sha256": "2d2727acac874bdb56f04acbbf3713f8b0f0cd5c63ed787ec40a0efb43b0e2a1", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\extracted\\BioInvent_Q4_2025_SE_Final\\BioInvent_Q4_2025_SE_Final.txt", "text_chars": 64011, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q4\\extracted\\BioInvent_Q4_2025_SE_Final\\BioInvent_Q4_2025_SE_Final.extraction.json" } } ], "announcement_id": "1422686", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:42Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari - september 2025", "category": "Interimsrapport", "date": "2025-10-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q3", "period": "2025-q3", "report_key": "2025:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=b758b8ef9cd3ea8cc78fd117758642c86&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\release.txt", "attachments": [ { "label": "BioInvent Q3 2025 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/aaf62030777dde1c77b31a87decc7bd13", "final_url": "https://attachment.news.eu.nasdaq.com/aaf62030777dde1c77b31a87decc7bd13", "filename": "BioInvent_Q3_2025_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\BioInvent_Q3_2025_SE.pdf", "content_type": "application/pdf", "size": 2587662, "sha256": "aa97c4a88aa00b4c59994f746f13afa80d91ae6f51ceda1f600b038aab6b10e4", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\BioInvent_Q3_2025_SE.pdf", "filename": "BioInvent_Q3_2025_SE.pdf", "extension": ".pdf", "size": 2587662, "sha256": "aa97c4a88aa00b4c59994f746f13afa80d91ae6f51ceda1f600b038aab6b10e4", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\extracted\\BioInvent_Q3_2025_SE\\BioInvent_Q3_2025_SE.txt", "text_chars": 62170, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q3\\extracted\\BioInvent_Q3_2025_SE\\BioInvent_Q3_2025_SE.extraction.json" } } ], "announcement_id": "1397286", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:48Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari - juni 2025", "category": "Halvårsrapport", "date": "2025-08-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q2", "period": "2025-q2", "report_key": "2025:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=b5be98a3ef48295226895d8270ed14d8e&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\release.txt", "attachments": [ { "label": "BioInvent Q2 2025 SE 25 Augusti.pdf", "url": "https://attachment.news.eu.nasdaq.com/ad1e4a43e2a0a70f0f24a5ec5030dc63b", "final_url": "https://attachment.news.eu.nasdaq.com/ad1e4a43e2a0a70f0f24a5ec5030dc63b", "filename": "BioInvent_Q2_2025_SE_25_Augusti.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\BioInvent_Q2_2025_SE_25_Augusti.pdf", "content_type": "application/pdf", "size": 3209953, "sha256": "eeb118e6a4b98d146a147018439761cecf789891a2277744590fe9fb3634b4ce", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\BioInvent_Q2_2025_SE_25_Augusti.pdf", "filename": "BioInvent_Q2_2025_SE_25_Augusti.pdf", "extension": ".pdf", "size": 3209953, "sha256": "eeb118e6a4b98d146a147018439761cecf789891a2277744590fe9fb3634b4ce", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\extracted\\BioInvent_Q2_2025_SE_25_Augusti\\BioInvent_Q2_2025_SE_25_Augusti.txt", "text_chars": 58410, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q2\\extracted\\BioInvent_Q2_2025_SE_25_Augusti\\BioInvent_Q2_2025_SE_25_Augusti.extraction.json" } } ], "announcement_id": "1385236", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T08:59:54Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari - mars 2025", "category": "Interimsrapport", "date": "2025-04-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2025, "quarter": "q1", "period": "2025-q1", "report_key": "2025:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4ead05c5608663c73175af63f2171ab2&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\release.txt", "attachments": [ { "label": "BioInvent Q1 2025 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a93fd97dcbb69c06a98bbca3d7915bb01", "final_url": "https://attachment.news.eu.nasdaq.com/a93fd97dcbb69c06a98bbca3d7915bb01", "filename": "BioInvent_Q1_2025_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\BioInvent_Q1_2025_SE.pdf", "content_type": "application/pdf", "size": 3936421, "sha256": "1bde995565aefd97353a9ada785e5cca9fced64bec2afdf11882a57e3c20d3ba", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\BioInvent_Q1_2025_SE.pdf", "filename": "BioInvent_Q1_2025_SE.pdf", "extension": ".pdf", "size": 3936421, "sha256": "1bde995565aefd97353a9ada785e5cca9fced64bec2afdf11882a57e3c20d3ba", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\extracted\\BioInvent_Q1_2025_SE\\BioInvent_Q1_2025_SE.txt", "text_chars": 56957, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2025-q1\\extracted\\BioInvent_Q1_2025_SE\\BioInvent_Q1_2025_SE.extraction.json" } } ], "announcement_id": "1359005", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:08Z", "company": "BioInvent International AB", "title": "BioInvent International AB publicerar årsredovisningen för 2024", "category": "Bokslut och Verksamhetsberättelse", "date": "2025-04-04", "language": "sv", "report_type": "annual-report", "fiscal_year": 2024, "quarter": "annual", "period": "2024-annual", "report_key": "2024:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b1b104722ee5caed8feac68349be1c315&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\release.txt", "attachments": [ { "label": "BioInvent AR 2024 SE FINAL.pdf", "url": "https://attachment.news.eu.nasdaq.com/a81b8869e169747bb6eb2e0628e40d1c6", "final_url": "https://attachment.news.eu.nasdaq.com/a81b8869e169747bb6eb2e0628e40d1c6", "filename": "BioInvent_AR_2024_SE_FINAL.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\BioInvent_AR_2024_SE_FINAL.pdf", "content_type": "application/pdf", "size": 11277499, "sha256": "01966b16031def74138efc849144ab9f45c904525300f2a9102c2b212247dd63", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\BioInvent_AR_2024_SE_FINAL.pdf", "filename": "BioInvent_AR_2024_SE_FINAL.pdf", "extension": ".pdf", "size": 11277499, "sha256": "01966b16031def74138efc849144ab9f45c904525300f2a9102c2b212247dd63", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\extracted\\BioInvent_AR_2024_SE_FINAL\\BioInvent_AR_2024_SE_FINAL.txt", "text_chars": 264240, "metadata": { "page_count": 84, "empty_pages": 1, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-annual\\extracted\\BioInvent_AR_2024_SE_FINAL\\BioInvent_AR_2024_SE_FINAL.extraction.json" } } ], "announcement_id": "1353800", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:11Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Bokslutskommuniké 1 januari - 31 december 2024", "category": "Bokslutskommuniké", "date": "2025-02-27", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2024, "quarter": "q4", "period": "2024-q4", "report_key": "2024:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=b4325ea86558e37754645d98a44d9fcb9&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\release.txt", "attachments": [ { "label": "BioInvent Q4 2024 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4e46e0f8f95e50791a1efc8f5291065e", "final_url": "https://attachment.news.eu.nasdaq.com/a4e46e0f8f95e50791a1efc8f5291065e", "filename": "BioInvent_Q4_2024_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\BioInvent_Q4_2024_SE_Final.pdf", "content_type": "application/pdf", "size": 3183016, "sha256": "84f9d860cd29baa7e8faa628a471da8d32e7f31ae82dea8c5b947383677bad6d", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\BioInvent_Q4_2024_SE_Final.pdf", "filename": "BioInvent_Q4_2024_SE_Final.pdf", "extension": ".pdf", "size": 3183016, "sha256": "84f9d860cd29baa7e8faa628a471da8d32e7f31ae82dea8c5b947383677bad6d", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\extracted\\BioInvent_Q4_2024_SE_Final\\BioInvent_Q4_2024_SE_Final.txt", "text_chars": 63027, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q4\\extracted\\BioInvent_Q4_2024_SE_Final\\BioInvent_Q4_2024_SE_Final.extraction.json" } } ], "announcement_id": "1345602", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:16Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-september 2024", "category": "Interimsrapport", "date": "2024-10-31", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q3", "period": "2024-q3", "report_key": "2024:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=bd4cfcd01dd2b8b94214bd849bb5735a4&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\release.txt", "attachments": [ { "label": "BioInvent Q3 2024 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a6f0722ec763ee02c5204b7bb5397531e", "final_url": "https://attachment.news.eu.nasdaq.com/a6f0722ec763ee02c5204b7bb5397531e", "filename": "BioInvent_Q3_2024_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\BioInvent_Q3_2024_SE_Final.pdf", "content_type": "application/pdf", "size": 3195895, "sha256": "240176b82d9e84f7441753a319c02de449d5a7332909d6f0c16bdc5b0dc6d422", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\BioInvent_Q3_2024_SE_Final.pdf", "filename": "BioInvent_Q3_2024_SE_Final.pdf", "extension": ".pdf", "size": 3195895, "sha256": "240176b82d9e84f7441753a319c02de449d5a7332909d6f0c16bdc5b0dc6d422", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\extracted\\BioInvent_Q3_2024_SE_Final\\BioInvent_Q3_2024_SE_Final.txt", "text_chars": 64135, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q3\\extracted\\BioInvent_Q3_2024_SE_Final\\BioInvent_Q3_2024_SE_Final.extraction.json" } } ], "announcement_id": "1324785", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:23Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-juni 2024", "category": "Halvårsrapport", "date": "2024-08-29", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q2", "period": "2024-q2", "report_key": "2024:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bb820dcd84852a821843b4d764b9a506c&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\release.txt", "attachments": [ { "label": "BioInvent Q2 2024 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a8c9a195497c084357930d08809bd444d", "final_url": "https://attachment.news.eu.nasdaq.com/a8c9a195497c084357930d08809bd444d", "filename": "BioInvent_Q2_2024_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\BioInvent_Q2_2024_SE_Final.pdf", "content_type": "application/pdf", "size": 3201474, "sha256": "d87a7337d230474edc9255512d8e54ec176e2ae3b84aa7701ad9a01665f29f65", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\BioInvent_Q2_2024_SE_Final.pdf", "filename": "BioInvent_Q2_2024_SE_Final.pdf", "extension": ".pdf", "size": 3201474, "sha256": "d87a7337d230474edc9255512d8e54ec176e2ae3b84aa7701ad9a01665f29f65", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\extracted\\BioInvent_Q2_2024_SE_Final\\BioInvent_Q2_2024_SE_Final.txt", "text_chars": 65072, "metadata": { "page_count": 27, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q2\\extracted\\BioInvent_Q2_2024_SE_Final\\BioInvent_Q2_2024_SE_Final.extraction.json" } } ], "announcement_id": "1313464", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:26Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-mars 2024", "category": "Interimsrapport", "date": "2024-04-24", "language": "sv", "report_type": "interim-report", "fiscal_year": 2024, "quarter": "q1", "period": "2024-q1", "report_key": "2024:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b7f72929e5278ad28f6fadbf66ec061a8&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\release.txt", "attachments": [ { "label": "BioInvent Q1 2024 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a02eeedd16b87572fea4fcf26b0036b83", "final_url": "https://attachment.news.eu.nasdaq.com/a02eeedd16b87572fea4fcf26b0036b83", "filename": "BioInvent_Q1_2024_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\BioInvent_Q1_2024_SE_Final.pdf", "content_type": "application/pdf", "size": 2524931, "sha256": "2330486ede597bccc52644461b86760db9c1fe658e5b7f0be2699431033a1d77", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\BioInvent_Q1_2024_SE_Final.pdf", "filename": "BioInvent_Q1_2024_SE_Final.pdf", "extension": ".pdf", "size": 2524931, "sha256": "2330486ede597bccc52644461b86760db9c1fe658e5b7f0be2699431033a1d77", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\extracted\\BioInvent_Q1_2024_SE_Final\\BioInvent_Q1_2024_SE_Final.txt", "text_chars": 57224, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2024-q1\\extracted\\BioInvent_Q1_2024_SE_Final\\BioInvent_Q1_2024_SE_Final.extraction.json" } } ], "announcement_id": "1289997", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:38Z", "company": "BioInvent International AB", "title": "BioInvent International AB publicerar Årsredovisning 2023", "category": "Bokslut och Verksamhetsberättelse", "date": "2024-04-04", "language": "sv", "report_type": "annual-report", "fiscal_year": 2023, "quarter": "annual", "period": "2023-annual", "report_key": "2023:annual", "release_url": "https://view.news.eu.nasdaq.com/view?id=b5a27e4b656010db5805548be94869731&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\release.txt", "attachments": [ { "label": "BioInvent AR 2023 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a364100d8e3ca8d4be33a4e4eb14893b9", "final_url": "https://attachment.news.eu.nasdaq.com/a364100d8e3ca8d4be33a4e4eb14893b9", "filename": "BioInvent_AR_2023_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\BioInvent_AR_2023_SE.pdf", "content_type": "application/pdf", "size": 8647388, "sha256": "ed832cbeb1c10ece3a28450f47b49f338d8d1000b6e892991e84f7de368cbd3f", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\BioInvent_AR_2023_SE.pdf", "filename": "BioInvent_AR_2023_SE.pdf", "extension": ".pdf", "size": 8647388, "sha256": "ed832cbeb1c10ece3a28450f47b49f338d8d1000b6e892991e84f7de368cbd3f", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\extracted\\BioInvent_AR_2023_SE\\BioInvent_AR_2023_SE.txt", "text_chars": 253055, "metadata": { "page_count": 82, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-annual\\extracted\\BioInvent_AR_2023_SE\\BioInvent_AR_2023_SE.extraction.json" } } ], "announcement_id": "1285746", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:41Z", "company": "BioInvent International AB", "title": "BioInvent International AB Bokslutskommuniké 1 januari - 31 december 2023", "category": "Bokslutskommuniké", "date": "2024-02-22", "language": "sv", "report_type": "year-end-report", "fiscal_year": 2023, "quarter": "q4", "period": "2023-q4", "report_key": "2023:q4", "release_url": "https://view.news.eu.nasdaq.com/view?id=bcad389850ce081669e8db0814075b534&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\release.txt", "attachments": [ { "label": "BioInvent Q4 2023 SE 21 Februari.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2412234949072bf59eac8ed22b6f1633", "final_url": "https://attachment.news.eu.nasdaq.com/a2412234949072bf59eac8ed22b6f1633", "filename": "BioInvent_Q4_2023_SE_21_Februari.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\BioInvent_Q4_2023_SE_21_Februari.pdf", "content_type": "application/pdf", "size": 1938033, "sha256": "2d189019d4289cc37d2484e846ec7a2e9eb1432009e169b77e34fc954b2566e7", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\BioInvent_Q4_2023_SE_21_Februari.pdf", "filename": "BioInvent_Q4_2023_SE_21_Februari.pdf", "extension": ".pdf", "size": 1938033, "sha256": "2d189019d4289cc37d2484e846ec7a2e9eb1432009e169b77e34fc954b2566e7", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\extracted\\BioInvent_Q4_2023_SE_21_Februari\\BioInvent_Q4_2023_SE_21_Februari.txt", "text_chars": 59858, "metadata": { "page_count": 25, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q4\\extracted\\BioInvent_Q4_2023_SE_21_Februari\\BioInvent_Q4_2023_SE_21_Februari.extraction.json" } } ], "announcement_id": "1276558", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:46Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-september 2023", "category": "Interimsrapport", "date": "2023-10-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q3", "period": "2023-q3", "report_key": "2023:q3", "release_url": "https://view.news.eu.nasdaq.com/view?id=be3c96a549266656b51480317ea317825&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\release.txt", "attachments": [ { "label": "BioInvent Q3 2023 SE.pdf", "url": "https://attachment.news.eu.nasdaq.com/a4d494801f274a18bac47cb87692323de", "final_url": "https://attachment.news.eu.nasdaq.com/a4d494801f274a18bac47cb87692323de", "filename": "BioInvent_Q3_2023_SE.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\BioInvent_Q3_2023_SE.pdf", "content_type": "application/pdf", "size": 1943418, "sha256": "f088a9b62e0de2fddf99459d82055070e218251219008656016d322dc900782e", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\BioInvent_Q3_2023_SE.pdf", "filename": "BioInvent_Q3_2023_SE.pdf", "extension": ".pdf", "size": 1943418, "sha256": "f088a9b62e0de2fddf99459d82055070e218251219008656016d322dc900782e", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\extracted\\BioInvent_Q3_2023_SE\\BioInvent_Q3_2023_SE.txt", "text_chars": 55909, "metadata": { "page_count": 24, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q3\\extracted\\BioInvent_Q3_2023_SE\\BioInvent_Q3_2023_SE.extraction.json" } } ], "announcement_id": "1254987", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:52Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-juni 2023", "category": "Halvårsrapport", "date": "2023-08-30", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q2", "period": "2023-q2", "report_key": "2023:q2", "release_url": "https://view.news.eu.nasdaq.com/view?id=bf4bf34de03398ac4aa733181ca29a635&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\release.txt", "attachments": [ { "label": "BioInvent Q2 2023 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/a2ca36c1ee58d29ec5d20efefaa15b8d0", "final_url": "https://attachment.news.eu.nasdaq.com/a2ca36c1ee58d29ec5d20efefaa15b8d0", "filename": "BioInvent_Q2_2023_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\BioInvent_Q2_2023_SE_Final.pdf", "content_type": "application/pdf", "size": 1781627, "sha256": "266f99d8d9266ae077b85ffdfca158499eff19828176065eb8f8742e17c79dad", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\BioInvent_Q2_2023_SE_Final.pdf", "filename": "BioInvent_Q2_2023_SE_Final.pdf", "extension": ".pdf", "size": 1781627, "sha256": "266f99d8d9266ae077b85ffdfca158499eff19828176065eb8f8742e17c79dad", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\extracted\\BioInvent_Q2_2023_SE_Final\\BioInvent_Q2_2023_SE_Final.txt", "text_chars": 57056, "metadata": { "page_count": 26, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q2\\extracted\\BioInvent_Q2_2023_SE_Final\\BioInvent_Q2_2023_SE_Final.extraction.json" } } ], "announcement_id": "1245201", "status": "retrieved" }, { "source": "Nasdaq Nordic", "fetcher_build": "2026-08-03-nasdaq-cns-annual-period-v5.0.10", "retrieved_at": "2026-08-04T09:00:58Z", "company": "BioInvent International AB", "title": "BioInvent International AB: Delårsrapport januari-mars 2023", "category": "Interimsrapport", "date": "2023-04-26", "language": "sv", "report_type": "interim-report", "fiscal_year": 2023, "quarter": "q1", "period": "2023-q1", "report_key": "2023:q1", "release_url": "https://view.news.eu.nasdaq.com/view?id=b66bfb93a046b6bf82a485c034c6d0a45&lang=sv&src=listed", "release_html_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\release.html", "release_text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\release.txt", "attachments": [ { "label": "BioInvent Q1 2023 SE Final.pdf", "url": "https://attachment.news.eu.nasdaq.com/afbe6ff197068f6b7d4cbebf39b901af2", "final_url": "https://attachment.news.eu.nasdaq.com/afbe6ff197068f6b7d4cbebf39b901af2", "filename": "BioInvent_Q1_2023_SE_Final.pdf", "local_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\BioInvent_Q1_2023_SE_Final.pdf", "content_type": "application/pdf", "size": 1678521, "sha256": "dd69154f612588fe8b682c646a8b90d596286f7c55ae6eb5c35ca0596f7bdbe9", "extraction": { "source_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\BioInvent_Q1_2023_SE_Final.pdf", "filename": "BioInvent_Q1_2023_SE_Final.pdf", "extension": ".pdf", "size": 1678521, "sha256": "dd69154f612588fe8b682c646a8b90d596286f7c55ae6eb5c35ca0596f7bdbe9", "status": "extracted", "text_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\extracted\\BioInvent_Q1_2023_SE_Final\\BioInvent_Q1_2023_SE_Final.txt", "text_chars": 53310, "metadata": { "page_count": 23, "empty_pages": 0, "encrypted": false }, "children": [], "warnings": [], "manifest_path": "D:\\Web\\aktieanalys\\data\\bioinvent-international\\nasdaq-reports\\reports\\2023-q1\\extracted\\BioInvent_Q1_2023_SE_Final\\BioInvent_Q1_2023_SE_Final.extraction.json" } } ], "announcement_id": "1222518", "status": "retrieved" } ], "attempts": [ { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "71b0568f5670e1cb00591905a5b15c80bccc8fc0edd695c9ef0ed1a157d6148e" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "d1a96dd7eba42268a49d1947b396ba43403a24a96c1aeaf127cd502a5d03f87b" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 200, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "fa6170f170fb53bdb246cd9a98dcb258f937c18cf13775eb6e3b7434703e6d52" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=300&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 300, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "4f13c7eb9aa89371336ef23cd37f12bf87a421bd8123d5ce84d13a8d93a73840" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=400&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 400, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 78, "new_rows": 78, "total_count": null, "from_cache": false, "body_sha256": "4504469a458eae32638d108b6231b0ff571d13beffe1afd5b6f898f3313e7b9a" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=478&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "sv", "start": 478, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "7f362898a354d586aed67605b31fb84815439ffc9e5e10d8b87efe0c3d2a13bd" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 6, "new_rows": 6, "total_count": null, "from_cache": false, "body_sha256": "7d2138c2193ceaba8bd1fb8eccfaffd03ef8d103dab0ed32280ac3cf97dfe5ec" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=sv&language=sv&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=6&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "sv", "start": 6, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "bd9c05e04ff6560502e6bf3875897cb7834465fc4920a52158db62f481ce3d43" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "62226978e75c738f0028fd73eedf8551118acd163d3f5ce8849e438cc9fc01e2" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=100&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 100, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 100, "new_rows": 100, "total_count": null, "from_cache": false, "body_sha256": "42de964744c066c7629b56ec17194fa0084efd21e506088cb5985125e2925e7c" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=200&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 200, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 64, "new_rows": 64, "total_count": null, "from_cache": false, "body_sha256": "bb8d5b3893491ebb7fba771252d4a0c3864d298fee0be8c3afd00b333f2fa8fb" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicMainMarkets&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=264&dir=DESC", "status": 200, "scope": "NordicMainMarkets", "language": "en", "start": 264, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "06f5e52c67c6fba3f6f9b9fd287533b230d1e7560e2f28da37dff687155f8b0d" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=0&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 0, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 5, "new_rows": 5, "total_count": null, "from_cache": false, "body_sha256": "f5b1dd2d65bd1cff4873e65438b3c185e93292b18659c34a4f310a392c2b0786" }, { "url": "https://api.news.eu.nasdaq.com/news/query.action?type=handleResponse&showAttachments=true&showCnsSpecific=true&showCompany=true&countResults=true&freeText=BioInvent+International&company=&market=&cnscategory=&fromDate=2023-01-01&toDate=&globalGroup=exchangeNotice&globalName=NordicFirstNorth&displayLanguage=en&language=en&timeZone=CET&dateMask=yyyy-MM-dd+HH%3Amm%3Ass&limit=100&start=5&dir=DESC", "status": 200, "scope": "NordicFirstNorth", "language": "en", "start": 5, "pagination": "row-offset", "query_text": "BioInvent International", "from_date": "2023-01-01", "to_date": "", "cache_tag": "broad", "rows": 0, "new_rows": 0, "total_count": null, "from_cache": false, "body_sha256": "d97ee824ab5793095b25a383238d191f6e98476d65197a4c886f360e00a0680f" } ], "identity": { "slug": "binv", "instrument_id": "TX351", "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/binv?id=TX351" }, "transport": "ordinary-http", "browser_used": false, "query_text": "BioInvent International", "retrieved_at": "2026-08-04T09:00:58Z" }